TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial.

Daniel H PalmerJuan W ValleYuk Ting MaOlusola FaluyiJohn P NeoptolemosTrine Jensen GjertsenBerit IversenJon Amund EriksenAnne-Sophie MøllerAnne-Kirsti AksnesRobert MillerSvein Dueland

Published in: British journal of cancer (2020)

This clinical trial was registered at ClinicalTrials.gov (NCT02261714).

Keyphrases

clinical trial
wild type
locally advanced
early stage
image quality
computed tomography
squamous cell carcinoma
dual energy
lymph node
contrast enhanced
phase ii
study protocol
rectal cancer
open label
double blind
magnetic resonance imaging
randomized controlled trial